Jahr 2019
- Primary Therapy of Early Breast Cancer: Evidence, Controversies, Consensus: Spectrum of Opinion of German Specialists on the 16th St. Gallen International Breast Cancer Conference (Vienna 2019). 2019
- 279th Statement of the German Society of Gynecology and Obstetrics (DGGG) on Abemaciclib (Breast Cancer, Combination with an Aromatase Inhibitor) - Benefit Assessment according to 35a SGB V 2019
- Chemotherapy (CT)-induced anaemia in patients (pts) treated with dose-dense regimen: Results of the prospectively randomised anaemia substudy from the neoadjuvant GeparOcto study 2019
- mRNA signatures predict response to durvalumab therapy in triple negative breast cancer (TNBC) Results of the translational biomarker programme of the neoadjuvant double-blind placebo controlled GeparNuevo trial 2019
- The FANCM:p.Arg658* truncating variant is associated with risk of triple-negative breast cancer. 2019
- Tumor budding: A predictor for metastasis in the CAM xenograft model 2019
- [Resilience, Fear of Progression and Psychosocial Distress in Patients with Breast Cancer and Gynecological Tumors Seeking a Second Opinion]. 2019
- Investigation of the efficacy of imidazolyl ethanamide pentandioic acid (IEPA) to reduce chemotherapy-induced myelosuppression (CIM) in breast cancer patients. 2019
- A randomised phase II study investigating durvalumab in addition to an anthracycline taxane-based neoadjuvant therapy in early triple-negative breast cancer: clinical results and biomarker analysis of GeparNuevo study. 2019
- Impact of single nucleotide polymorphisms in the VEGFR2 gene on endothelial cell activation under non‑uniform shear stress. 2019
- Prediction and clinical utility of a contralateral breast cancer risk model. 2019
- Exosome-based intercellular communication in female reproductive microenvironments. 2019
- Diagnosis and Therapy of Triple-Negative Breast Cancer (TNBC) - Recommendations for Daily Routine Practice. 2019
- Correlation of short-term variation and Doppler parameters with adverse perinatal outcome in small-for-gestational age fetuses at term. 2019
- 280th Statement of the Committee Mamma of the Working Group on Gynecological Oncology (AGO) e. V. in the German Society of Gynecology and Obstetrics e. V. (DGGG) on the Pharmaceuticals Guidelines Ribociclib 2019
- Dear Readers 2019
- Therapy landscape of patients with metastatic, HER2 positive breast cancer - Data from the real world breast cancer registry PRAEGNANT (NCT02338167) 2019
- Salivary and hair cortisol as biomarkers of emotional and behavioral symptoms in 6-9 year old children. 2019
- Treatment of Early Breast Cancer Patients: Evidence, Controversies, Consensus: Focusing on Systemic Therapy - German Experts' Opinions for the 16th International St. Gallen Consensus Conference (Vienna 2019) 2019
- Concept Paper on the Technique of Cryopreservation, Removal and Transplantation of Ovarian Tissue for Fertility Preservation. 2019
- RIBECCA: A phase IIIb, multicenter, open label study for women with estrogen receptor-positive locally advanced or metastatic breast cancer treated with ribociclib (LEE011) in combination with letrozole-Results of the second interim analysis. 2019
- Publisher Correction: Shared heritability and functional enrichment across six solid cancers. 2019
- Adrenarche and pubarche in girls with turner syndrome during growth-promoting therapy with human growth hormone. 2019
- AGO Recommendations for the Diagnosis and Treatment of Patients with Early Breast Cancer: Update 2019. 2019
- Can a University Reproductive Medicine Centre Be Financed Under the Pre-Existing General Conditions in Germany? 2019
- Statement of the German Society for Gynecology and Obstetrics (DGGG) on the S18-01 Preliminary Report "Screening for Sickle Cell Disease (SCD) in Newborns" 2019
- Dear Readers 2019
- Immunomonitoring of triple negative breast cancer patients undergoing neoadjuvant therapy with durvalumab - Results from the prospectively randomized GeparNuevo trial 2019
- Awareness of breast cancer incidence and risk factors among healthy women in Germany: an update after 10 years. 2019
- Tumour immune microenvironment drives prognostic relevance correlating with bladder cancer subtypes 2019
- Quality of life and oncological outcome in endometrial cancer patients after vaginal brachytherapy: comparison of two dosing schemes. 2019
- Germline mutation status and therapy response in high-risk early breast cancer: Results of the GeparOcto study (NCT02125344). 2019
- Evaluation of soluble carbonic anhydrase IX as predictive marker for efficacy of bevacizumab: A biomarker analysis from the geparquinto phase III neoadjuvant breast cancer trial. 2019
- Clarifications concerning the commentary "Published analysis of contraceptive effectiveness of Daysy and DaysyView app is fatally flawed". 2019
- AGO Recommendations for the Diagnosis and Treatment of Patients with Locally Advanced and Metastatic Breast Cancer: Update 2019. 2019
- Induction of Labour in Growth Restricted and Small for Gestational Age Foetuses - A Historical Cohort Study. 2019
- Berlin, 05.04.2018. Statement of the German Society for Gynecology and Obstetrics (DGGG) on the Report Plan S17-02 Version 1.0 Screening of Streptococci of the serological Group B 26.02.2018 2019
- Joint association of mammographic density adjusted for age and body mass index and polygenic risk score with breast cancer risk. 2019
- PRAEGNANT - Real world evidence, translational research, big and smart data: A prospective academic translational research network for the optimization of the oncological health care quality in the adjuvant and advanced/metastatic setting (NCT02338167) 2019
- Analysis of GDF15 and IGFBP7 in Hyperemesis Gravidarum Support Causality. 2019
- Clinical and analytical validation of Ki-67 in 9069 patients from IBCSG VIII + IX, BIG1-98 and GeparTrio trial: systematic modulation of interobserver variance in a comprehensive in silico ring trial. 2019
- Associations of prenatal depressive symptoms with DNA methylation of HPA axis-related genes and diurnal cortisol profiles in primary school-aged children. 2019
- NATALEE: Phase III study of ribociclib (RIBO) plus endocrine therapy (ET) as adjuvant treatment in hormone receptor-positive (HR plus ), human epidermal growth factor receptor 2-negative (HER2-) early breast cancer (EBC). 2019
- Genetic Data from Nearly 63,000 Women of European Descent Predicts DNA Methylation Biomarkers and Epithelial Ovarian Cancer Risk. 2019
- Real-world effectiveness of ribociclib plus aromatase inhibitor, or endocrine monotherapy, or chemotherapy as first-line treatment in postmenopausal women with HR-positive, HER2-negative locally advanced or metastatic breast cancer: Baseline data from the RIBANNA study. 2019
- Androgen receptor expression and response to chemotherapy in breast cancer patients treated in the neoadjuvant TECHNO and PREPARE trial. 2019
- Maintenance tocolysis: a reappraisal of clinical evidence. 2019
- Association between breast cancer risk factors and molecular type in postmenopausal patients with hormone receptor-positive early breast cancer. 2019
- Identification of a neoantigen targeted by tumor-infiltrating lymphocytes in a patient with Her2+breast cancer 2019
- Prevention of Cervical Cancer: Guideline of the DGGG and the DKG (S3 Level, AWMF Register Number 015/027OL, December 2017) - Part 1 with Introduction, Screening and the Pathology of Cervical Dysplasia. 2019
- Berlin, 24.01.2019. 271 Statement of the German Society for Gynecology and Obstetrics (DGGG) on the Health Information Draft from the IQWiG on "Ovarian Cysts" 2019
- Translational highlights in breast cancer research and treatment: recent developments with clinical impact. 2019
- Identification of a neoantigen targeted by tumor-infiltrating lymphocytes in a patient with Her2+breast cancer 2019
- Presence of Circulating Tumor Cells in High-Risk Early Breast Cancer During Follow-Up and Prognosis. 2019
- Impact of chemotherapy-induced ovarian failure (CIOF) on disease-free survival (DFS) and overall survival (OS) in young women with early breast cancer (EBC) 2019
- A Phase II Study of Talazoparib after Platinum or Cytotoxic Nonplatinum Regimens in Patients with Advanced Breast Cancer and Germline BRCA1/2 Mutations (ABRAZO). 2019
- Dear Readers 2019
- Human leucocyte antigen class I in hormone receptor-positive, HER2-negative breast cancer: association with response and survival after neoadjuvant chemotherapy. 2019
- Influence of patient and tumor characteristics on therapy persistence with letrozole in postmenopausal women with advanced breast cancer: results of the prospective observational EvAluate-TM study. 2019
- KATHERINE: Trastuzumab emtansine vs trastuzumab as adjuvant therapy in patients with HER2-positive early breast cancer 2019
- Prevention of Cervical Cancer: Guideline of the DGGG and the DKG (S3 Level, AWMF Register Number 015/027OL, December 2017) - Part 2 on Triage, Treatment and Follow-up. 2019
- Berlin, 12.03.2019 275th Statement of the Working Group on Gynecological Oncology (AGO) of the German Society for Gynecology and Obstetrics (DGGG) about the IQWiG Health Information "Therapy-related Hair Loss" 2019
- An Electronic Patient-Reported Outcome Tool for the FACT-B (Functional Assessment of Cancer Therapy-Breast) Questionnaire for Measuring the Health-Related Quality of Life in Patients With Breast Cancer: Reliability Study. 2019
- Progression free survival (PFS) and overall survival (OS) of patients treated with trastuzumab emtansine (T-DM1) after previous treatment with pertuzumab in patients with advanced breast cancer (NCT02338167) 2019
- Preexisting musculoskeletal burden and its development under letrozole treatment in early breast cancer patients. 2019
- Comparative analysis of tumour mutational burden (TMB) prediction methods and its association with determinants of the tumour immune microenvironment of urothelial bladder cancer (UBC) 2019
- The impact of mammalian target of rapamycin inhibition on bone health in postmenopausal women with hormone receptor-positive advanced breast cancer receiving everolimus plus exemestane in the phase IIIb 4EVER trial. 2019
- Dear Readers 2019
- Update Breast Cancer 2019 Part 5 - Diagnostic and Therapeutic Challenges of New, Personalised Therapies in Patients with Advanced Breast Cancer. 2019
- Therapy Landscape in Patients with Metastatic HER2-Positive Breast Cancer: Data from the PRAEGNANT Real-World Breast Cancer Registry. 2019
- Treatment of severe traumatic brain injury in German pediatric intensive care units-a survey of current practice. 2019
- [Induction of Labour In Growth Restricted and Small for Gestational Age Fetuses - A Historical Cohort Study]. 2019
- Berlin, 25.04.2019 277th Statement of the Commission Mamma of the Working Group on Gynecological Oncology (AGO) e. V. in the German Society of Gynecology and Obstetrics e. V. about Palbociclib (Breast Cancer) - Benefit Assessment according to 35a SGB V 2019
- A Phase II Randomized Study of Neoadjuvant Letrozole Plus Alpelisib for Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer (NEO-ORB). 2019
- Pre-therapeutic PD-L1 expression and dynamics of Ki-67 and gene expression during neoadjuvant immunecheckpoint blockade and chemotherapy to predict response within the GeparNuevo trial 2019
- Induction of labour with sequential double-balloon catheter and oral misoprostol versus oral misoprostol alone in obese women. 2019
- Fatal events during clinical trials: an evaluation of deaths during breast cancer studies. 2019
- NAB-Paclitaxel Improves Disease-Free Survival in Early Breast Cancer: GBG 69-GeparSepto. 2019
- Trastuzumab Emtansine for Residual Invasive HER2-Positive Breast Cancer. 2019
- Final results of the ASG1-3 study, a randomized phase III study comparing a standard dose chemotherapy with epirubicin/cyclophosphamide and paclitaxel with a dose dense regimen with epirubicin and paclitaxel 2019
- Translational Highlights in Breast and Ovarian Cancer 2019 - Immunotherapy, DNA Repair, PI3K Inhibition and CDK4/6 Therapy. 2019
- Intense dose-dense epirubicin, paclitaxel, cyclophosphamide versus weekly paclitaxel, liposomal doxorubicin (plus carboplatin in triple-negative breast cancer) for neoadjuvant treatment of high-risk early breast cancer (GeparOcto-GBG 84): A randomised phase III trial. 2019
- Filarial extract of Litomosoides sigmodontis induces a type 2 immune response and attenuates plaque development in hyperlipidemic ApoE-knockout mice. 2019
- Diagnosis, Therapy and Follow-up of Vaginal Cancer and Its Precursors. Guideline of the DGGG and the DKG (S2k-Level, AWMF Registry No. 032/042, October 2018). 2019
- Berlin, 24.08.2018 Statement of the German Society for Gynecology and Obstetrics (DGGG) and the German Society for Perinatal Medicine (DGPM) on the IQWIG Preliminary Report S17/02-Screening of Streptococci of serological Group B as a Part of Preventive Examinations according to Maternity Guidelines 2019
- Development of central nervous system metastases as a first site of metastatic disease in breast cancer patients treated in the neoadjuvant trials GeparQuinto and GeparSixto. 2019
- Similarities between low hormone receptor positive and hormone receptor negative breast cancer: An analysis of 4366 patients from multicenter clinical trials 2019
- Comparison of preoperative and postoperative sexual function in patients with deeply infiltrating endometriosis with and without bowel resection. 2019
- Mutational Diversity and Therapy Response in Breast Cancer: A Sequencing Analysis in the Neoadjuvant GeparSepto Trial. 2019
- Efficacy and safety of everolimus plus exemestane in postmenopausal women with hormone receptor-positive, human epidermal growth factor receptor 2-negative locally advanced or metastatic breast cancer: Results of the single-arm, phase IIIB 4EVER trial. 2019
- Retraction Note: Improving usability and pregnancy rates of a fertility monitor by an additional mobile application: results of a retrospective efficacy study of Daysy and DaysyView app. 2019
- Update Breast Cancer 2019 Part 4 - Diagnostic and Therapeutic Challenges of New, Personalised Therapies for Patients with Early Breast Cancer. 2019
- Efficacy of neoadjuvant pertuzumab in addition to chemotherapy and trastuzumab in routine clinical treatment of patients with primary breast cancer: a multicentric analysis. 2019
- Influence of PIK3CA mutations on breast cancer proliferation, lymphocyte infiltration and clinical outcome: Pooled analysis of 484 patients from three prospective multicentre GBG trials 2019
- Sarcoma of the Uterus. Guideline of the DGGG and OEGGG (S2k Level, AWMF Register Number 015/074, February 2019). 2019
- Berlin, 22.10.2018. 270th Statement of the Working Group of Gynecological Oncology (AGO) e. V. in the German Society for Gynecology and Obstetrics (DGGG) e. V. on the Subject of Pertuzumab (Breast Cancer) - Benefit Assessment according to 35a SGB V 2019
- The prognostic relevance of urokinase-type plasminogen activator (uPA) in the blood of patients with metastatic breast cancer. 2019
- Validation of different prognostic scores in breast cancer patients with brain metastases of the BMBC registry (GBG-79) 2019
- Novel approach for the assessment of ovarian follicles infiltration in polymeric electrospun patterned scaffolds. 2019
- Neoadjuvant Trastuzumab Emtansine and Pertuzumab in Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: Three-Year Outcomes From the Phase III KRISTINE Study. 2019
- Malignant ascites occurs most often in patients with high-grade serous papillary ovarian cancer at initial diagnosis: a retrospective analysis of 191 women treated at Bayreuth Hospital, 2006-2015. 2019
- Influence of Low Protein Diet-Induced Fetal Growth Restriction on the Neuroplacental Corticosterone Axis in the Rat. 2019
- Diagnosis and Therapy Before Assisted Reproductive Treatments. Guideline of the DGGG, OEGGG and SGGG (S2k Level, AWMF Register Number 015-085, February 2019) - Part 1, Basic Assessment of the Woman. 2019
- Differential prognostic relevance of patho-anatomical factors among different tumor-biological subsets of breast cancer: Results from the adjuvant SUCCESS A study. 2019
- Evaluation of pathological complete response as a trial-level surrogate for long-term survival outcomes among triple-negative breast cancer patients receiving neoadjuvant therapy 2019
- Standards Used by a Clinical and Scientific Endometriosis Center for the Diagnosis and Therapy of Patients with Endometriosis. 2019
- Berlin, 14.03.2017 Statement of the German Society for Gynecology and Obstetrics (DGGG) on "P15-02 Invitation Letters and Decision Aid for Cervical Cancer Screening" 2019
- The genetic interplay between body mass index, breast size and breast cancer risk: a Mendelian randomization analysis. 2019
- RIBANNA Real-world evidence of ribociclib plus aromatase inhibitor, or endocrine monotherapy, or chemotherapy as first-line therapy for postmenopausal women with HR+, HER2 advanced breast cancer (aBC) 2019
- The effect of bpV(HOpic) on in vitro activation of primordial follicles in cultured swine ovarian cortical strips. 2019
- Electrospun patterned porous scaffolds for the support of ovarian follicles growth: a feasibility study. 2019
- Event Report 11th Scientific Symposium of the AGO TraFo 2019
- Design and Implementation of a Single Source Multipurpose Hospital-Wide Clinical Trial Registry. 2019
- SHEAR STRESS-DEPENDENT EXPRESSION OF GLYPICAN-4 AND HEPARAN SULFATE IN DIFFERENT PRIMARY HUMAN ENDOTHELIAL CELLS 2019
- Diagnosis and Treatment Before Assisted Reproductive Treatments. Guideline of the DGGG, OEGGG and SGGG (S2k Level, AWMF Register Number 015-085, February 2019) - Part 2, Hemostaseology, Andrology, Genetics and History of Malignant Disease. 2019
- Accuracy of colposcopy-directed biopsy in detecting early cervical neoplasia: a retrospective study. 2019
- Impact of objective response (OR) on patient-reported outcomes (PRO) in patients (pts) with advanced breast cancer (ABC) and a germline BRCA1/2 (gBRCA) mutation in the phase III EMBRACA trial 2019
- Two truncating variants in FANCC and breast cancer risk 2019
- 257a Statement by the German Society for Gynaecology and Obstetrics e. V. (DGGG) on biomarker-based Tests to decide whether or not to use adjuvant systemic Chemotherapy for primary Breast Cancer 2019
- Different nutrient intake and prevalence of gastrointestinal comorbidities in women with endometriosis. 2019
- Venous air embolism due to vaginal injuries through sexual intercourse. Critical analysis and review of the literature on frequency and diagnostics 2019
- Ovarian Tissue Transplantation: Experience From Germany and Worldwide Efficacy. 2019
- International pooled analysis of the prognostic impact of disseminated tumor cells from the bone marrow in early breast cancer: Results from the PADDY study 2019
- Genome-wide association and transcriptome studies identify target genes and risk loci for breast cancer. 2019
- The Tumor Immune Microenvironment Drives a Prognostic Relevance That Correlates with Bladder Cancer Subtypes. 2019
- Next-generation DNA sequencing (NGS) results for tumours from phase II ABRAZO study of talazoparib after platinum or cytotoxic non-platinum regimens in patients (pts) with advanced breast cancer (ABC) and germline BRCA1/2 (gBRCA) mutations 2019
- Correlation of short-term variation and Doppler parameters with adverse perinatal outcome in low-risk fetuses at term. 2019
- Associations of obesity and circulating insulin and glucose with breast cancer risk: a Mendelian randomization analysis. 2019
- Genetic predictors of chemotherapy-related amenorrhea in women with breast cancer. 2019
- 257b Statement by the German Society for Gynaecology and Obstetrics e. V. (DGGG) on biomarker-based Tests to decide whether or not to use adjuvant systemic Chemotherapy for primary Breast Cancer 2019
- Response to "Letter to the Editor" by Federico Prefumo. 2019
- Dear Reader 2019
- Berlin, 04.06.2019 Statement of the DGGG on the Health Information/Accompanying Information of the IQWiG "What are the Benefits of Screening for B-Streptococci in Pregnancy?" and "What is the Use of Determining the Rhesus factor before Birth?" 2019
- Intra- and Postoperative Blood Flow Monitoring in a Sheep Model of Uterus Transplantation. 2019
- Factors predicting relapse in early breast cancer patients with a pathological complete response after neoadjuvant therapy - Results of a pooled analysis based on the GBG meta-database 2019
- Prognostic effect of Ki-67 in common clinical subgroups of patients with HER2-negative, hormone receptor-positive early breast cancer. 2019
- Meta-analysis on association of pathological complete response with long-term survival outcomes in triple-negative breast cancer 2019
- [Induction of Labour in Nulliparous Women Beyond Term in a Low-Risk Population]. 2019
- GeparOLA: A randomized phase II trial to assess the efficacy of paclitaxel and olaparib in comparison to paclitaxel/carboplatin followed by epirubicin/cyclophosphamide as neoadjuvant chemotherapy in patients (pts) with HER2-negative early breast cancer (B 2019
- Cost effectiveness of bilateral risk-reducing mastectomy and salpingo-oophorectomy 2019
- Functional Analysis and Fine Mapping of the 9p22.2 Ovarian Cancer Susceptibility Locus 2019
- Prenatal diagnosis of HNF1B-associated renal cysts: Is there a need to differentiate intragenic variants from 17q12 microdeletion syndrome? 2019
- Berlin, 12.06.2018. 281 Opinion of the German Society for Gynecology and Obstetrics (DGGG) on substitution-based Treatment of Opiate Addicts 2019
- Plasticity of patient-matched normal mammary epithelial cells is dependent on autologous adipose-derived stem cells. 2019
- Lifestyle Intervention and Effect on Disease-free Survival in Early Breast Cancer Pts: Interim Analysis from the Randomized SUCCESS C Study 2019
- Diagnostic Accuracy of Breast Medical Tactile Examiners (MTEs): A Prospective Pilot Study. 2019
- PRECYCLE Impact of CANKADO-based eHealth-support on quality of life in metastatic breast cancer patients treated with palbociclib and endocrine therapy 2019
- Can Sonographic Fetal Biometry Predict Adverse Perinatal Outcome? 2019
- Germline BRCA1 and BRCA2 mutations in patients with HER2-negative metastatic breast cancer (mBC) treated with first-line chemotherapy: Data from the German PRAEGNANT registry. 2019
- Response to Di Cosimo, Torri, and Porcu. 2019
- Accelerated partial breast irradiation with external beam radiotherapy: results of the German phase 2-trial 2019
- Update Breast Cancer 2019 Part 1 - Implementation of Study Results of Novel Study Designs in Clinical Practice in Patients with Early Breast Cancer. 2019
- Berlin, 30.01.2019 Statement of the DGGG on the IQWiG-Commission HT17-02 preliminary Basic Report on the HTA Report "Cancer: Can a concomitant Music Therapy contribute to better Treatment Results?" 2019
- Dear Readers 2019
- DETECT V/CHEVENDO - Comparison of dual HER2-targeted therapy with trastuzumab plus pertuzumab in combination with chemo- or endocrine therapy in addition with CDK4/6 inhibition in patients with HER2-positive and hormone-receptor positive metastatic breast cancer 2019
- Characterization of Molecular Subtypes of Paget Disease of the Breast Using Immunohistochemistry and In Situ Hybridization. 2019
- KEYNOTE-522: Phase III study of pembrolizumab (pembro) plus chemotherapy (chemo) vs placebo (pbo) plus chemo as neoadjuvant treatment, followed by pembro vs pbo as adjuvant treatment for early triple-negative breast cancer (TNBC) 2019
- Reliability of prenatal detection of X-linked hypohidrotic ectodermal dysplasia by tooth germ sonography. 2019
- Neoadjuvant trastuzumab (H), pertuzumab (P), and chemotherapy versus trastuzumab emtansine (T-DM1) and P in human epidermal growth factor receptor 2 (H ER2)-positive breast cancer (BC): Final outcome results from the phase III KRISTINE study. 2019
- Shared heritability and functional enrichment across six solid cancers. 2019
- Oncoplastic breast-conserving surgery: More relevant than ever? Results of a survey among breast surgeons. 2019
- Update Breast Cancer 2019 Part 2 - Implementation of Novel Diagnostics and Therapeutics in Advanced Breast Cancer Patients in Clinical Practice. 2019
- Update Breast Cancer 2019 Part 3 - Current Developments in Early Breast Cancer: Review and Critical Assessment by an International Expert Panel. 2019
- Berlin, 19.02.2019 278th Statement of the German Society for Gynecology and Obstetrics (DGGG) on Abemaciclib (Breast Cancer, Combination with Fulvestrant) - Benefit Assessment according to 35a SGB V 2019
- Utility of the CPS plus EG scoring system in triple-negative breast cancer treated with neoadjuvant chemotherapy 2019
- DETECT III/IV study trial - The multicenter study program in patients with HER2-negative metastatic breast cancer and circulating tumor cells 2019
- Genome-wide association study of germline variants and breast cancer-specific mortality. 2019
- Overall survival (OS) results of the phase III MONALEESA-3 trial of postmenopausal patients (pts) with hormone receptor-positive (HR plus ), human epidermal growth factor 2-negative (HER2-) advanced breast cancer (ABC) treated with fulvestrant (FUL) (+) ribociclib (RIB) 2019
- Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes. 2019
- Exome analysis of oncogenic pathways and tumor mutational burden (TMB) in triple-negative breast cancer (TNBC): Results of the translational biomarker program of the neoadjuvant double-blind placebo controlled GeparNuevo trial. 2019
- Editorial: The potential for precision medicine to improve care and speed the development of new treatments in breast and gynecologic malignancies. 2019
- Follicular Fluid Levels of Adrenomedullin 2, Vascular Endothelial Growth Factor and its Soluble Receptors Are Associated with Ovarian Response During ART Cycles. 2019